Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Capital One
COF
|
+$445M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$405M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$387M |
| 4 |
Johnson & Johnson
JNJ
|
+$256M |
| 5 |
Procter & Gamble
PG
|
+$170M |
Top Sells
| 1 |
DFS
Discover Financial Services
DFS
|
+$536M |
| 2 |
NVIDIA
NVDA
|
+$471M |
| 3 |
X
US Steel
X
|
+$421M |
| 4 |
JPMorgan Chase
JPM
|
+$237M |
| 5 |
Deere & Co
DE
|
+$235M |
Sector Composition
| 1 | Technology | 20.97% |
| 2 | Financials | 18.52% |
| 3 | Industrials | 12.24% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Healthcare | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2851
Sight Sciences
SGHT
$193M
| $1.24M | ﹤0.01% |
300,583
+2,686
| +0.9% | +$11.1K |
|
2852
Ark Restaurants
ARKR
$25.9M
| $1.24M | ﹤0.01% |
136,134
-600
| -0.4% | -$5.48K |
|
2853
Smith-Midland
SMID
$223M
| $1.24M | ﹤0.01% |
36,834
| – | – |
|
|
ONL
2854
Orion Office REIT
ONL
$171M
| $1.23M | ﹤0.01% |
579,444
-104,408
| -15% | -$222K |
|
2855
Star Holdings Shares of Beneficial Interest
STHO
$116M
| $1.22M | ﹤0.01% |
156,829
+45,793
| +41% | +$358K |
|
2856
GSI Technology
GSIT
$85.5M
| $1.22M | ﹤0.01% |
362,784
+14,697
| +4% | +$49.4K |
|
2857
Grab
GRAB
$21.6B
| $1.22M | ﹤0.01% |
241,634
-30,111
| -11% | -$151K |
|
2858
ORIX
IX
$29.8B
| $1.21M | ﹤0.01% |
53,855
-80
| -0.1% | -$1.8K |
|
2859
UWM Holdings
UWMC
$1.41B
| $1.2M | ﹤0.01% |
290,202
+111,725
| +63% | +$463K |
|
|
LENZ
2860
LENZ Therapeutics
LENZ
$1.14B
| $1.2M | ﹤0.01% |
40,886
-895
| -2% | -$26.3K |
|
2861
Astria Therapeutics
ATXS
$419M
| $1.18M | ﹤0.01% |
220,909
+36,830
| +20% | +$197K |
|
2862
Pulmonx
LUNG
$69.3M
| $1.18M | ﹤0.01% |
455,344
+58,090
| +15% | +$150K |
|
2863
Madrigal Pharmaceuticals
MDGL
$10.1B
| $1.17M | ﹤0.01% |
3,870
+26
| +0.7% | +$7.87K |
|
|
NIU
2864
Niu Technologies
NIU
$336M
| $1.14M | ﹤0.01% |
340,154
+8,768
| +3% | +$29.5K |
|
2865
Bausch + Lomb
BLCO
$5.49B
| $1.14M | ﹤0.01% |
87,399
-33,406
| -28% | -$434K |
|
2866
TIM SA
TIMB
$10.1B
| $1.13M | ﹤0.01% |
56,332
+10,918
| +24% | +$220K |
|
2867
Black Diamond Therapeutics
BDTX
$185M
| $1.13M | ﹤0.01% |
455,870
-116,600
| -20% | -$289K |
|
2868
Affinity Bancshares
AFBI
$124M
| $1.12M | ﹤0.01% |
60,673
+2,315
| +4% | +$42.8K |
|
2869
iRobot
IRBT
$106M
| $1.12M | ﹤0.01% |
357,843
-111,502
| -24% | -$349K |
|
2870
Genmab
GMAB
$16.9B
| $1.1M | ﹤0.01% |
53,105
+2,284
| +4% | +$47.2K |
|
|
ATYR
2871
aTyr Pharma
ATYR
$520M
| $1.09M | ﹤0.01% |
214,546
-13,548
| -6% | -$68.7K |
|
2872
Solid Biosciences
SLDB
$389M
| $1.08M | ﹤0.01% |
222,338
-47,143
| -17% | -$230K |
|
2873
Auburn National Bancorp
AUBN
$97M
| $1.07M | ﹤0.01% |
41,401
+1,519
| +4% | +$39.3K |
|
2874
CF Bankshares
CFBK
$164M
| $1.06M | ﹤0.01% |
44,415
+8,525
| +24% | +$204K |
|
2875
Cytokinetics
CYTK
$6.23B
| $1.06M | ﹤0.01% |
32,086
+1,052
| +3% | +$34.8K |
|